Home / Cefazolin / United States
US ATC J01DB04 · updated 3 Nov 2026
Cefazolin shortage in United States
Is there a Cefazolin shortage in United States?
Yes. As of 3 Nov 2026, 3 Cefazolin products are reported short in United States, the first since 30 Oct 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Spain, Czechia, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Cefazolin in Dextrose, Injection, 1g/50 mL (NDC 0338-3503-41) discontinuation | Baxter Healthcare | 30 Oct 2026 | not given | Not stated |
| US | Cefazolin in Dextrose, Injection, 2g/100mL (NDC 0338-3508-41) discontinuation | Baxter Healthcare | 30 Oct 2026 | not given | Not stated |
| US | Cefazolin in Dextrose, Injection, 3g/150mL (NDC 0338-0096-06) discontinuation | Baxter Healthcare | 30 Oct 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).